Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probucol in Diabetic Nephropathy
NCT01726816Phase 2Completed
- Sponsor
- Otsuka Holdings
- Start
- Oct 2012
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of probucol in diabetic nephropathy (DN), sponsored by Otsuka Holdings. Started Oct 2012; status: completed.
02
Drugs
probucol
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT01726816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01726816.